Nootropil

Nootropil Use In Pregnancy & Lactation

piracetam

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
Full Prescribing Info
Use In Pregnancy & Lactation
Fertility: There are no relevant data available.
Pregnancy: Piracetam (Nootropil) should not be used during pregnancy unless clearly necessary, when benefit exceeds the risks and the clinical condition of the pregnant mother requires treatment with piracetam (Nootropil). Piracetam (Nootropil) crosses the placental barrier. Drug levels in the newborn are approximately 70% to 90% of maternal levels. There are no adequate data from the use of piracetam (Nootropil) in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or post-natal development.
Lactation: Piracetam (Nootropil) should not be used during breastfeeding or breastfeeding should be discontinued, while receiving treatment with piracetam (Nootropil). Piracetam (Nootropil) is excreted in human breast milk. A decision must be made whether to discontinue breast-feeding or to discontinue piracetam (Nootropil) therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in